Kenneth M. Cohen, President and CEO at Somaxon Pharmaceuticals, Inc. (SOMX), sold 609 shares at $12.50 ($8K) on 2006-10-04, disclosed to the SEC on 2006-10-04.
Scheduled sale ($8k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.62 | 525 | $7K | 86.3% |
| 2 | $12.50 | 84 | $1K | 13.7% |
| Total | $12.60 avg | 609 | $8K | 100% |
| Filing → |
| MBVX | BUY | 2014-12-18 | $5K | — | Filing → |
| MBVX | BUY | 2014-12-17 | $10K | — | Filing → |
| SOMX | SELL | 2007-04-27 | $360K | — | Filing → |